Boundless Bio, Inc.
BOLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782303
In the last 90 days, Boundless Bio, Inc. insiders filed 4 open-market purchases and 2 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $38.3M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Boundless Bio, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 35 | 36 | +1 |
| Shares | 9.62M | 8.78M | −840.4K (−8.7%) |
| Value | $11.8M | $10.5M | −$1.30M (−11.0%) |
New holders (6)
Institutions that held Boundless Bio, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Landscape Capital Management, L.L.C. | 127,626 | $153.2K | 0.01% |
| Gsa Capital Partners LLP | 62,476 | $75.0K | 0.01% |
| Citigroup Inc | 25,073 | $30.1K | 0.00% |
| Jane Street Group, LLC | 13,323 | $16.0K | 0.00% |
| Nolet Wealth Management, LLC | 11,323 | $13.6K | 0.01% |
| JPMorgan Chase & Co | 169 | $203 | 0.00% |
Sold out (5)
Institutions that held Boundless Bio, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Nextech Invest, Ltd. | 1,228,069 | $1.51M |
| Redmile Group, LLC | 245,458 | $301.9K |
| Almitas Capital LLC | 86,808 | $106.8K |
| Squarepoint Ops LLC | 50,771 | $62.4K |
| Goldman Sachs Group Inc | 14,299 | $17.6K |